Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander R Abbas

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Cancer Cell|November 6, 2020
Molecular Subsets in Renal Cancer Determine Outcome to Checkpoint and Angiogenesis BlockadeRobert J Motzer, Romain Banchereau, Habib Hamidi, et al.
Cell Reports. Medicine|November 29, 2025
Molecular subtypes of hepatocellular carcinoma linked to liver cell lineages and clinical outcomes of combination immunotherapyYulei Wang, Yinghui Guan, Alexander R Abbas, et al.
The Lancet. Respiratory Medicine|June 13, 2018
Analysis of protein-altering variants in telomerase genes and their association with MUC5B common variant status in patients with idiopathic pulmonary fibrosis: a candidate gene sequencing studyAmy Dressen, Alexander R Abbas, Christopher Cabanski, et al.
Ebiomedicine|April 16, 2021
The transition from normal lung anatomy to minimal and established fibrosis in idiopathic pulmonary fibrosis (IPF)Feng Xu, Naoya Tanabe, Dragos M Vasilescu, et al.
Science Translational Medicine|August 21, 2015
TH2 and TH17 inflammatory pathways are reciprocally regulated in asthmaDavid F Choy, Kevin M Hart, Lee A Borthwick, et al.
The Journal of Allergy and Clinical Immunology|April 29, 2022
Genome-wide association study identifies kallikrein 5 in type 2 inflammation-low asthmaJanet K Jackman, Amy Stockwell, David F Choy, et al.
Science Translational Medicine|August 5, 2021
TGFβ2 and TGFβ3 isoforms drive fibrotic disease pathogenesisTianhe Sun, Zhiyu Huang, Wei-Ching Liang, et al.
Biorxiv : the Preprint Server for Biology|January 7, 2026
Combined antagonism of Oncostatin M (OSM) and Interleukin 6 (IL-6) provides both anti-fibrotic and anti-inflammatory benefit in pulmonary fibrosisRojo A Ratsimandresy, Emma Doran, Hart S Dengler, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Cancer Cell|November 6, 2020
Molecular Subsets in Renal Cancer Determine Outcome to Checkpoint and Angiogenesis BlockadeRobert J Motzer, Romain Banchereau, Habib Hamidi, et al.
Cell Reports. Medicine|November 29, 2025
Molecular subtypes of hepatocellular carcinoma linked to liver cell lineages and clinical outcomes of combination immunotherapyYulei Wang, Yinghui Guan, Alexander R Abbas, et al.
The Lancet. Respiratory Medicine|June 13, 2018
Analysis of protein-altering variants in telomerase genes and their association with MUC5B common variant status in patients with idiopathic pulmonary fibrosis: a candidate gene sequencing studyAmy Dressen, Alexander R Abbas, Christopher Cabanski, et al.
Ebiomedicine|April 16, 2021
The transition from normal lung anatomy to minimal and established fibrosis in idiopathic pulmonary fibrosis (IPF)Feng Xu, Naoya Tanabe, Dragos M Vasilescu, et al.
Science Translational Medicine|August 21, 2015
TH2 and TH17 inflammatory pathways are reciprocally regulated in asthmaDavid F Choy, Kevin M Hart, Lee A Borthwick, et al.
The Journal of Allergy and Clinical Immunology|April 29, 2022
Genome-wide association study identifies kallikrein 5 in type 2 inflammation-low asthmaJanet K Jackman, Amy Stockwell, David F Choy, et al.
Science Translational Medicine|August 5, 2021
TGFβ2 and TGFβ3 isoforms drive fibrotic disease pathogenesisTianhe Sun, Zhiyu Huang, Wei-Ching Liang, et al.
Biorxiv : the Preprint Server for Biology|January 7, 2026
Combined antagonism of Oncostatin M (OSM) and Interleukin 6 (IL-6) provides both anti-fibrotic and anti-inflammatory benefit in pulmonary fibrosisRojo A Ratsimandresy, Emma Doran, Hart S Dengler, et al.
Pageof 3